The Liposome Company, Inc.

Basic Information

One Research Way, Princeton Fo
Rrestal Center
Princeton, NJ, 08540

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. WE PROPOSE TO DEVELOP A GENTAMICIN LIPOSOME-CONTROLLED RELEASE FORMULATION SUITABLE FOR TOPICAL TREATMENT OF BACTERIAL KERATITIS AND CONJUNCTIVITIS THAT PROVIDES EFFICACY AND SAFETY EQUAL TO OR BETTER THAN PRESENT THERAPY AND WHICH REQUIRES FEWER DOSES.

    Amount: $47,990.00

    WE PROPOSE TO DEVELOP A GENTAMICIN LIPOSOME-CONTROLLED RELEASE FORMULATION SUITABLE FOR TOPICAL TREATMENT OF BACTERIAL KERATITIS AND CONJUNCTIVITIS THAT PROVIDES EFFICACY AND SAFETY EQUAL TO OR BETTER ...

    SBIR Phase I 1985 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government